Effisayil 1 Archives - Medical Conferences

All patients with GPP benefit from IL-36 inhibitor therapy

Trial

Phase 2, Effisayil 1

Conference

SPIN 2022

Type

Peer-reviewed article

26 August 2022 10:37

IL-36 gene expression in GPP lesions reduced by spesolimab

Presented By

Dr Ahmed Farag

Conference

PFGC 2021

Type

Peer-reviewed article

2 February 2022 15:09

PFGC 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

PFGC 2021

22 December 2021 08:12

Rapid pustule and skin clearance with IL-36 receptor inhibitor spesolimab

Presented By

Prof. Hervé Bachelez, Hôpital Saint-Louis, France

Trial

Phase 2, Effisayil 1

Conference

WPPAC 2021

Type

Peer-reviewed article

17 September 2021 11:04

site created by:

© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy

HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com